✦ LIBER ✦

Preclinical and clinical investigation of a CCR5 antagonist, AZD5672, in patients with rheumatoid arthritis receiving methotrexate

✍ Scribed by Daniëlle M. Gerlag; Sally Hollis; Mark Layton; Jiří Vencovský; Zoltán Szekanecz; Martin Braddock; Paul P. Tak; ESCAPE Study Group

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 152 KB
Volume: 62
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.27652

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Radiographic healing with sustained clin

Radiographic healing with sustained clinical remission in a patient with rheumatoid arthritis receiving methotrexate monotherapy

✍ Siegfried Wassenberg; Rolf Rau 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB 👁 2 views

Lack of association between hla–dr2 and

Lack of association between hla–dr2 and clinical response to methotrexate in patients with rheumatoid arthritis

✍ Graciela S. Alarcóan; Lynn M. Billingsley; Daniel O. Clegg; Joe G. Hardin; John 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 291 KB 👁 2 views

Acute febrile toxic reaction in patients

Acute febrile toxic reaction in patients with refractory rheumatoid arthritis who are receiving combined therapy with methotrexate and azathioprine

✍ Ricardo Blanco; Victor M. Martínez-Taboada; Miguel A. González-Gay; Jose Armona; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 489 KB 👁 2 views

## Objective: To assess the frequency and clinical features of an acute febrile toxic reaction (aftr) in patients with refractory rheumatoid arthritis (ra) receiving combined therapy with methotrexate (mtx) and azathioprine (aza). ## Methods: A cohort of 43 ra patients being treated with mtx/aza

Progression of radiologic damage in pati

Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission

✍ Esmeralda T. H. Molenaar; Alexandre E. Voskuyl; Huib J. Dinant; P. Dick Bezemer; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

Pharmacokinetics of methotrexate adminis

Pharmacokinetics of methotrexate administered by intramuscular and subcutaneous injections in patients with rheumatoid arthritis

✍ Paul J. Brooks; William J. Spruill; Roy C. Parish; Daniel A. Birchmore 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 326 KB 👁 2 views

MLN3897 plus methotrexate in patients wi

MLN3897 plus methotrexate in patients with rheumatoid arthritis: Safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study

✍ Clarissa E. Vergunst; Danielle M. Gerlag; Lisa von Moltke; Michael Karol; Tim Wy 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 2 views

## Abstract ## Objective To assess the efficacy, safety, pharmacokinetics, and pharmacodynamics of the CC chemokine receptor CCR1 antagonist MLN3897 in patients with rheumatoid arthritis (RA) receiving methotrexate (MTX). ## Methods In this phase IIa, proof‐of‐concept study, patients meeting the